Advisor Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $2.85M | Buy |
13,924
+1,548
| +13% | +$328K | 0.2% | 100 |
|
|
2022
Q1 | $2.94M | Buy |
12,376
+296
| +2% | +$69.5K | 0.18% | 102 |
|
|
2021
Q4 | $2.76M | Buy |
12,080
+1,162
| +11% | +$256K | 0.17% | 113 |
|
|
2021
Q3 | $2.11M | Sell |
10,918
-100
| -0.9% | -$20.3K | 0.14% | 147 |
|
|
2021
Q2 | $2.34M | Buy |
11,018
+87
| +0.8% | +$18.4K | 0.15% | 128 |
|
|
2021
Q1 | $2.23M | Buy |
10,931
+34
| +0.3% | +$6.7K | 0.16% | 128 |
|
|
2020
Q4 | $1.98M | Sell |
10,897
-1,611
| -13% | -$274K | 0.15% | 142 |
|
|
2020
Q3 | $2.09M | Buy |
12,508
+928
| +8% | +$156K | 0.18% | 106 |
|
|
2020
Q2 | $1.88M | Sell |
11,580
-1,930
| -14% | -$346K | 0.18% | 119 |
|
|
2020
Q1 | $2.34M | Buy |
13,510
+3,877
| +40% | +$772K | 0.28% | 67 |
|
|
2019
Q4 | $1.98M | Buy |
9,633
+376
| +4% | +$77.1K | 0.2% | 110 |
|
|
2019
Q3 | $1.96M | Buy |
9,257
+1,091
| +13% | +$228K | 0.24% | 84 |
|
|
2019
Q2 | $1.58M | Buy |
8,166
+492
| +6% | +$90.7K | 0.19% | 101 |
|
|
2019
Q1 | $1.26M | Sell |
7,674
-2,103
| -22% | -$372K | 0.16% | 125 |
|
|
2018
Q4 | $1.84M | Buy |
9,777
+1,844
| +23% | +$341K | 0.29% | 74 |
|
|
2018
Q3 | $1.35M | Sell |
7,933
-167
| -2% | -$28.1K | 0.18% | 103 |
|
|
2018
Q2 | $1.33M | Buy |
8,100
+486
| +6% | +$79.4K | 0.22% | 97 |
|
|
2018
Q1 | $1.23M | Buy |
7,614
+391
| +5% | +$62.2K | 0.23% | 98 |
|
|
2017
Q4 | $1.11M | Buy |
7,223
+1,010
| +16% | +$144K | 0.2% | 118 |
|
|
2017
Q3 | $843K | Buy |
6,213
+58
| +0.9% | +$7.33K | 0.17% | 130 |
|
|
2017
Q2 | $771K | Buy |
6,155
+341
| +6% | +$40.8K | 0.18% | 136 |
|
|
2017
Q1 | $691K | Buy |
5,814
+874
| +18% | +$105K | 0.18% | 131 |
|
|
2016
Q4 | $570K | Buy |
4,940
+326
| +7% | +$36.3K | 0.17% | 145 |
|
|
2016
Q3 | $482K | Sell |
4,614
-386
| -8% | -$40.3K | 0.16% | 153 |
|
|
2016
Q2 | $487K | Sell |
5,000
-20
| -0.4% | -$1.89K | 0.17% | 151 |
|
|
2016
Q1 | $482K | Buy |
5,020
+891
| +22% | +$81.1K | 0.18% | 145 |
|
|
2015
Q4 | $374K | Sell |
4,129
-208
| -5% | -$19.6K | 0.13% | 176 |
|
|
2015
Q3 | $402K | Sell |
4,337
-243
| -5% | -$23.1K | 0.17% | 159 |
|
|
2015
Q2 | $433K | Buy |
4,580
+431
| +10% | +$40.2K | 0.17% | 172 |
|
|
2015
Q1 | $393K | Buy |
4,149
+73
| +2% | +$6.76K | 0.17% | 177 |
|
|
2014
Q4 | $361K | Buy |
+4,076
| New | +$345K | 0.16% | 171 |
|
|
2014
Q3 | – | Sell |
-3,266
| Closed | -$232K | – | 240 |
|
|
2014
Q2 | $232K | Buy |
3,266
+84
| +3% | +$5.91K | 0.11% | 235 |
|
|
2014
Q1 | $236K | Buy |
3,182
+61
| +2% | +$4.6K | 0.13% | 221 |
|
|
2013
Q4 | $245K | Buy |
3,121
+395
| +14% | +$30.9K | 0.14% | 199 |
|
|
2013
Q3 | $201K | Buy |
+2,726
| New | +$201K | 0.14% | 211 |
|
Other funds holding CME
Advisor Partners's CME Position: Q2 2022 in Review
Advisor Partners increased its CME Group (CME) stake by 13% in Q2 2022, buying an estimated $328K and bringing the position to 13,924 shares worth $2.85M. The position accounts for 0.2% of the portfolio, ranked #100.
Advisor Partners first reported a position in CME in Q3 2013 and has held it in 35 quarters since. The position peaked at $2.94M in Q1 2022. 1,159 funds tracked by Wall St. Rank hold CME as of Q2 2022.
- Advisor Partners held 13,924 shares of CME Group worth $2.85M as of Q2 2022.
- Advisor Partners bought 1,548 CME Group shares in Q2 2022, an estimated $328K.
- CME Group made up 0.2% of Advisor Partners's portfolio in Q2 2022, its #100 holding.
- Advisor Partners first reported a position in CME Group in Q3 2013 and has held it in 35 quarters since.
- Advisor Partners's CME Group position peaked at $2.94M in Q1 2022.
- 1,159 funds tracked by Wall St. Rank held CME Group as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.